These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3757054)

  • 1. Activated human lymphocytes secrete a soluble factor that aggregates leukocytes.
    Rouveix B; Groult F; Levacher M
    Cell Immunol; 1986 May; 99(2):385-94. PubMed ID: 3757054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional characteristics of histamine receptor-bearing mononuclear cells. I. Selective production of lymphocyte chemoattractant lymphokines with histamine used as a ligand.
    Center DM; Cruikshank WW; Berman JS; Beer DJ
    J Immunol; 1983 Oct; 131(4):1854-9. PubMed ID: 6352807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-lactam antibiotics and human lymphocyte function: the in vitro effect on blastogenesis, lymphokine production and suppressor cell functions.
    Rouveix B; Groult F; Levacher M
    Int J Immunopharmacol; 1987; 9(5):567-75. PubMed ID: 2957332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage aggregation factor: some properties.
    Badenoch-Jones P
    Immunology; 1982 Jul; 46(3):629-34. PubMed ID: 6284638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphokines and thrombosis. I. Thrombocyte aggregating activity released by human lymphocytes stimulated with concanavalin-A.
    Coeugniet E; Bendixen G
    Acta Allergol; 1976 Apr; 31(2):94-106. PubMed ID: 947142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An improved assay for interleukin 2 (lymphocyte growth factor) produced by mitogen-activated lymphocytes.
    Lafferty KJ; Prowse SJ; Al-Adra A; Warren HS; Vasalli J; Reich E
    Aust J Exp Biol Med Sci; 1980 Dec; 58(6):533-44. PubMed ID: 6791621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial characterization of lymphokines that change the surface charge density of human polymorphonuclear leukocytes.
    Harthus HP; Hannig K
    Immunobiology; 1982; 162(2):141-52. PubMed ID: 7118152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amplification of the activity of human leukocyte inhibitory factor (LIF) by the generation of a low molecular weight inhibitor of PMN leukocyte chemotaxis.
    Goetzl EJ; Rocklin RE
    J Immunol; 1978 Sep; 121(3):891-6. PubMed ID: 690441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concanavalin A-induced macrophage aggregating factor.
    Badenoch-Jones P
    Aust J Exp Biol Med Sci; 1981 Oct; 59(Pt 5):575-83. PubMed ID: 7325889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical and biological characterization of lymphocyte regulatory molecules. I. Purification of a class of murine lymphokines.
    Watson J; Gillis S; Marbrook J; Mochizuki D; Smith KA
    J Exp Med; 1979 Oct; 150(4):849-61. PubMed ID: 315987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physicochemical characterization of chemotatic lymphokines produced by human T and B lymphocytes.
    Altman LC; Chassy B; Mackler BF
    J Immunol; 1975 Jul; 115(1):18-21. PubMed ID: 1097502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of monoclonal B cell growth factor (BCGF) produced by a human T-T hybridoma.
    Butler JL; Ambrus JL; Fauci AS
    J Immunol; 1984 Jul; 133(1):251-5. PubMed ID: 6427336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physicochemical characterization of a vascular permeability factor produced by con A-stimulated human lymphocytes.
    Sobel AT; Branellec AI; Blanc CJ; Lagrue GA
    J Immunol; 1977 Oct; 119(4):1230-4. PubMed ID: 894032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition and stimulation of leukocyte adherence by soluble factors from murine lymphocytes.
    Dunn IS; Halliday WJ
    Immunol Lett; 1981 Dec; 3(6):351-6. PubMed ID: 7338352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphokine-induced neutrophil aggregation.
    Badenoch-Jones P
    Immunology; 1982 Sep; 47(1):169-74. PubMed ID: 7118158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial purification and molecular characterization of a lymphokine (costimulator) required for the mitogenic response of mouse thymocytes in vitro.
    Shaw J; Monticone V; Paetkau V
    J Immunol; 1978 Jun; 120(6):1967-73. PubMed ID: 307026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional characteristics of histamine receptor-bearing mononuclear cells. II. Identification and characterization of two histamine-induced human lymphokines that inhibit lymphocyte migration.
    Berman JS; McFadden RG; Cruikshank WW; Center DM; Beer DJ
    J Immunol; 1984 Sep; 133(3):1495-504. PubMed ID: 6379050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukocyte migration inhibitory factor: a serine esterase released by stimulated human lymphocytes. Kinetic analysis and inhibition by cyclic GMP.
    Bendtzen K
    Biochim Biophys Acta; 1979 Jan; 566(1):183-91. PubMed ID: 215234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Charge-reducing lymphokine activity in Concanavalin A-stimulated lymphocyte supernatants: preliminary biological and biochemical characterization.
    Kotzsch M; Grossmann H; Irmscher J; Wagner H; Müller M
    Biomed Biochim Acta; 1984; 43(1):57-65. PubMed ID: 6372798
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of lymphocyte migration by human lymphokines. III. Characterization of a lymphocyte migration inhibitory factor (LyMIF35K).
    McFadden RG; Cruikshank WW; Center DM
    Cell Immunol; 1984 Apr; 85(1):154-67. PubMed ID: 6370461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.